MSH2 and colorectal carcinoma: More specifically, germline LPVs/PVs in MLH1 and MSH2 genes are associated with a higher lifetime CRC risk of 58–82%, while LPVs/PVs in MSH6 and PMS2 genes are associated with a lower lifetime CRC risk of 10–22% [30].